Chickenpox Vaccine – Safety, Side Effects and UK 2026 Schedule

The chickenpox vaccine is a safe and effective way to prevent varicella, a highly contagious disease. In the UK, the vaccine has been available privately for years, but a major policy change means it will be added to the routine NHS childhood schedule from 2026. This guide covers everything you need to know about safety, side effects, cost, and availability.

Chickenpox typically causes an itchy rash, fever, and fatigue, and can lead to serious complications in some people, including pneumonia and skin infections. The vaccine provides strong protection with a low risk of side effects. Understanding the facts can help you make an informed decision for yourself or your family.

Below we break down the key questions: Is it safe? What are the side effects? Why has the UK policy changed? And how much does it cost? All information is drawn from official health sources and recent NHS announcements.

Is the Chickenpox Vaccine Safe?

The chickenpox vaccine has a well-established safety record. Health authorities including the NHS, the UK Health Security Agency (UKHSA), and the US Centers for Disease Control and Prevention (CDC) all classify it as very safe. Serious adverse reactions are extremely rare, and the benefits of preventing severe disease far outweigh the risks.

What Are the Side Effects of the Chickenpox Vaccine?

Most people who receive the chickenpox vaccine experience no serious problems. The side effects that do occur are usually mild and resolve on their own. The vaccine is a live attenuated vaccine, meaning it contains a weakened form of the virus, which is why a mild rash can sometimes appear.

Common side effects

Injection-site reactions such as redness, pain, swelling, soreness, or itching are the most frequently reported effects. Fever is also common, as is a mild chickenpox-like rash. According to the Oxford Vaccine Knowledge Project, injection-site reactions and fever are very common, and a rash occurs in up to 10% of adults and 5% of children. Other symptoms can include tiredness, irritability, headache, sore throat, cough, or runny nose. These are typically mild and short-lived.

Serious side effects

Serious adverse events are very rare. Anaphylaxis, a severe allergic reaction, occurs in about 1 in a million vaccinated people, according to UK public health sources. Product information also lists possible events such as seizures, meningitis, severe rash, lung or liver infections, and severe infection with the vaccine-strain virus, but these are rare. UKHSA and the Oxford Vaccine Knowledge Project both emphasise that side effects from the vaccine are usually mild compared with the complications of natural chickenpox infection.

Do side effects differ in adults and children?

Both children and adults can experience fever, rash, and injection-site reactions. The Oxford Vaccine Knowledge Project notes that a chickenpox-like rash occurs in up to 10% of adults and 5% of children. The Green Book states that children and adults aged 9 months and older may receive two doses at least four weeks apart. The side effect profile is similar across age groups, though adults may be slightly more likely to report injection-site discomfort.

Why Isn’t the Chickenpox Vaccine Routinely Given in the UK?

For many years, the UK did not include the chickenpox vaccine in the routine childhood schedule. The Joint Committee on Vaccination and Immunisation (JCVI) reviewed the evidence but initially did not recommend routine vaccination due to cost-effectiveness concerns and a theoretical risk that widespread childhood vaccination could increase shingles rates in older adults. However, that position changed in 2023, and the UK is now preparing for a national rollout.

What is the new MMRV vaccine?

The NHS will use a combined MMRV vaccine, which protects against measles, mumps, rubella, and varicella (chickenpox) in a single injection. UKHSA’s 2025–2026 guidance names ProQuad® and Priorix-Tetra® as the MMRV vaccines. This approach simplifies the schedule and reduces the number of injections children need. The Green Book notes that the most reported reactions for both MMRV and monovalent varicella vaccines are injection-site pain, redness, and swelling, with fever and rash less common.

When will the chickenpox vaccine be routine?

NHS England announced in January 2026 that GP practices will begin offering the MMRV vaccine to children at 12 months and 18 months. This marks a significant policy shift after years of private-only access.

How Much Does the Chickenpox Vaccine Cost and Where Can I Get It?

Until the NHS rollout, the chickenpox vaccine is available privately through pharmacies and travel clinics. Prices vary by provider, and eligibility criteria may differ slightly.

Superdrug lists the chickenpox vaccination at £75 per dose and £150 for a full course of two doses. Boots also offers the vaccine, typically at a similar price point. It is advisable to check directly with the provider for current pricing and availability. Private vaccination is an option for anyone who wants protection before the NHS programme begins.

Other private clinics and travel health centres also offer the chickenpox vaccine. Searching for “chickenpox vaccine near me” can help locate a provider. Private health insurance may cover the cost in some cases, but this is not guaranteed.

What Is the History of Chickenpox Vaccination in the UK?

The chickenpox vaccine has been licensed in the UK since the early 2000s, but its place in the national schedule has evolved slowly. Key milestones include:

1. 2000s: Chickenpox vaccine licensed in the UK but not added to routine schedule; available privately.
2. 2010s: JCVI reviews evidence but does not recommend routine vaccination due to cost-effectiveness concerns.
3. 2023: JCVI changes recommendation: chickenpox vaccine should be added to routine childhood schedule.
4. January 2026: NHS England announces that GP practices will offer combined MMRV vaccine at 12 months and 18 months starting from 2026.

What Is Known and What Remains Uncertain About the Chickenpox Vaccine?

While much is well-established, some areas continue to be studied. The table below separates what is known with confidence from what still carries some uncertainty.

Why Is the UK Changing Its Vaccination Policy?

The UK was one of the few developed countries without routine chickenpox vaccination. The United States, Canada, Australia, and many European countries have had routine programmes for years. The decision to introduce the vaccine in the UK follows updated modelling and evidence reviews by the JCVI.

The delay in routine vaccination was partly due to concerns about a potential increase in shingles among older adults. However, recent modelling suggests that the risk is manageable and that the benefits of preventing chickenpox and its complications outweigh this theoretical concern. The choice to use MMRV instead of a separate varicella vaccine simplifies the schedule and reduces the number of injections.

Private vaccination has remained available for those who want it before the NHS rollout. The new policy will eventually make the vaccine accessible to all children as part of the routine programme.

For more on health and cultural topics, see the Wellcome Collection – Free Museum and Library in London.

What Do Official Sources Say About the Chickenpox Vaccine?

Official health bodies consistently emphasise the safety and effectiveness of the vaccine. Key statements include:

“The chickenpox vaccine is very safe and effective at preventing chickenpox.”

— NHS

“The vaccine is around 90% effective at preventing chickenpox and 95% effective at preventing severe disease.”

— Oxford Vaccine Knowledge Project

“Hundreds of thousands of young children now to be protected against chickenpox as GP practices start to offer the MMRV vaccine.”

— NHS England press release, January 2026

These sources form the basis of the information in this guide. For further reading, refer to the NHS chickenpox vaccine page, the Oxford Vaccine Knowledge Project, and the NHS England announcement.

What Should You Remember About the Chickenpox Vaccine?

The chickenpox vaccine is a safe, effective, and increasingly accessible way to prevent a potentially serious illness. With the UK moving to routine NHS vaccination from 2026, more people than ever will be protected. Private options remain available for those who need vaccination sooner. If you are unsure whether you or your child should be vaccinated, speak to a healthcare professional. For a look at another prominent figure’s health and financial journey, see Duncan Bannatyne – Net Worth, Family and Health in 2025.

Frequently Asked Questions